🔗 Bio: bit.ly/Christie_JonLim
(tennis enthusiast 🎾)
We’re excited to launch our flagship TIL Summit in Manchester: "Unlocking TIL Therapy: A New Era for Melanoma Care in the UK"
🗓 11 March 2026
📍 The Midland Hotel, Manchester
We’re excited to launch our flagship TIL Summit in Manchester: "Unlocking TIL Therapy: A New Era for Melanoma Care in the UK"
🗓 11 March 2026
📍 The Midland Hotel, Manchester
Next #ChristieFellows session:
“Preparing a Grant Proposal for PhD or Research Projects”
🎤 Dr Jamie Weaver
🗓️ Tue 18 Nov 2025 | 12:30–13:30
📍 Seminar 4&5, Edu Centre
Learn how to pitch your idea & navigate the grant process from an early-career clinical academic.
#TeamManchester 🐝
Next #ChristieFellows session:
“Preparing a Grant Proposal for PhD or Research Projects”
🎤 Dr Jamie Weaver
🗓️ Tue 18 Nov 2025 | 12:30–13:30
📍 Seminar 4&5, Edu Centre
Learn how to pitch your idea & navigate the grant process from an early-career clinical academic.
#TeamManchester 🐝
Let’s connect and discuss the latest news here in Berlin >>> and beyond!
#ONEOncologyCommunity
@myesmo.bsky.social
Let’s connect and discuss the latest news here in Berlin >>> and beyond!
#ONEOncologyCommunity
@myesmo.bsky.social
Huge congrats on the ESMO Merit Award 🎉 So well deserved — proud of you, my friend! 💫
#ESMO25 #TranslationalResearch #TRACERxRenal
Huge congrats on the ESMO Merit Award 🎉 So well deserved — proud of you, my friend! 💫
#ESMO25 #TranslationalResearch #TRACERxRenal
📚 Special Educational Session on the state-of-the-art and future of cell therapies - evolving fast from promise to practice.
👀 Watch this space…
#ESMO25 #ESMOAmbassadors #CellTherapy #Immunotherapy
📚 Special Educational Session on the state-of-the-art and future of cell therapies - evolving fast from promise to practice.
👀 Watch this space…
#ESMO25 #ESMOAmbassadors #CellTherapy #Immunotherapy
Mini-oral presentation re: global phase 1 data on divarasib (GDC-6036) - a next-gen KRAS G12C inhibitor with promising activity.
#TeamManchester 🐝
@mcrcnews.bsky.social
Mini-oral presentation re: global phase 1 data on divarasib (GDC-6036) - a next-gen KRAS G12C inhibitor with promising activity.
#TeamManchester 🐝
@mcrcnews.bsky.social
#AICTteam
#TeamManchester 🐝
@mcrcnews.bsky.social
#AICTteam
#TeamManchester 🐝
@mcrcnews.bsky.social
Some of our core team from @christieinstitute.bsky.social are here at the #ESMO25 Congress - come say hi 👋!
Special shout-out to our #YoungOncologists colleagues - Always keen to connect, and discuss opportunities in Manchester. @mcrcnews.bsky.social
Some of our core team from @christieinstitute.bsky.social are here at the #ESMO25 Congress - come say hi 👋!
Special shout-out to our #YoungOncologists colleagues - Always keen to connect, and discuss opportunities in Manchester. @mcrcnews.bsky.social
Congrats to Maitane, and her supervisors Prof Charles Lawrie and Prof Andreas Seifert, on a successful defence! All the best for the future.
Congrats to Maitane, and her supervisors Prof Charles Lawrie and Prof Andreas Seifert, on a successful defence! All the best for the future.
Join a world-class team exploring how the microenvironment drives CRS in CAR-T therapy.
🌍 Open globally | 💥 Translational science
🗓️ Apply by 8 Nov 2025
🔗 www.findaphd.com/phds/project...
#PhDOpportunity #TeamManchester 🐝
@uom-dcs.bsky.social
Join a world-class team exploring how the microenvironment drives CRS in CAR-T therapy.
🌍 Open globally | 💥 Translational science
🗓️ Apply by 8 Nov 2025
🔗 www.findaphd.com/phds/project...
#PhDOpportunity #TeamManchester 🐝
@uom-dcs.bsky.social
Exciting times ahead for the field - collaboration between all stakeholders (NHS, academia, industry, regulators) is the key to success!
Exciting times ahead for the field - collaboration between all stakeholders (NHS, academia, industry, regulators) is the key to success!
🚀 Launching a refreshed Fellows’ Programme at @christieinstitute.bsky.social - focused on career development, leadership & opportunities to help trainees grow as future leaders, researchers & educators.
All fellows & residents @mcrcnews.bsky.social welcome!
🚀 Launching a refreshed Fellows’ Programme at @christieinstitute.bsky.social - focused on career development, leadership & opportunities to help trainees grow as future leaders, researchers & educators.
All fellows & residents @mcrcnews.bsky.social welcome!
Proud to represent #TeamManchester 🐝 & showcase our #immunotherapy + #celltherapy programmes, including #MANIFESTuk & soon-to-launch #RISE.
Global collaboration drives progress! 🌍✨
Proud to represent #TeamManchester 🐝 & showcase our #immunotherapy + #celltherapy programmes, including #MANIFESTuk & soon-to-launch #RISE.
Global collaboration drives progress! 🌍✨
🔹 Looking ahead – focusing on sustainability, long-term impact & training.
Privileged to represent such a committed team & grateful to hear feedback/ideas as we continue to shape MANIFEST together 🚀.
🔹 Looking ahead – focusing on sustainability, long-term impact & training.
Privileged to represent such a committed team & grateful to hear feedback/ideas as we continue to shape MANIFEST together 🚀.
Honoured to share our progress at the UK Cancer Research Strategy Forum held in London today, chaired by Prof Peter Johnson, as part of the Office for Life Sciences Cancer Mission.
On behalf of
@turajliclab.bsky.social
@manifest-cirrp.bsky.social
Honoured to share our progress at the UK Cancer Research Strategy Forum held in London today, chaired by Prof Peter Johnson, as part of the Office for Life Sciences Cancer Mission.
On behalf of
@turajliclab.bsky.social
@manifest-cirrp.bsky.social
A prestigious 12-month funded post at The Christie to develop world-class clinical, research & leadership skills in brain tumour care, working with experts.
Deadline: 5th Sep 2025
📥 For further information/to apply 👇
A prestigious 12-month funded post at The Christie to develop world-class clinical, research & leadership skills in brain tumour care, working with experts.
Deadline: 5th Sep 2025
📥 For further information/to apply 👇
🌍 This year, we welcomed 93 students from 42 countries! The future is bright. Great to see so many budding oncologists; so engaged, inquisitive & eager to learn - looking forward to seeing you all grow & join the field 🤩🙌.
🌍 This year, we welcomed 93 students from 42 countries! The future is bright. Great to see so many budding oncologists; so engaged, inquisitive & eager to learn - looking forward to seeing you all grow & join the field 🤩🙌.
Watch the space for Berlin 2025 🙌!
@myesmo.bsky.social
#BreakingNews
#PracticeChanging #ONEOncologyCommunity #educationforLIFE
Watch the space for Berlin 2025 🙌!
@myesmo.bsky.social
#BreakingNews
#PracticeChanging #ONEOncologyCommunity #educationforLIFE
🧑⚕️Our Advanced Immunotherapy & Cell Therapy team at The Christie is growing! We have a new post for a Band 6 Clinical Research Nurse to join us.
#TeamManchester 🐝
Deadline 23 July 2025.
🧑⚕️Our Advanced Immunotherapy & Cell Therapy team at The Christie is growing! We have a new post for a Band 6 Clinical Research Nurse to join us.
#TeamManchester 🐝
Deadline 23 July 2025.
Fantastic to hear the breadth & depth of our fellowship programme at The Christie - thanks to all the fellows who presented flash talks & for attending.
This makes us all really proud to be #TeamManchester 🐝 .
Fantastic to hear the breadth & depth of our fellowship programme at The Christie - thanks to all the fellows who presented flash talks & for attending.
This makes us all really proud to be #TeamManchester 🐝 .
🧑⚕️ An exciting forum to engage with enthusiastic clinicians & scientists working in cancer care & research. Very happy to share our experience launching @manifest-cirrp.bsky.social. Thanks for the invitation! 🙏
🧑⚕️ An exciting forum to engage with enthusiastic clinicians & scientists working in cancer care & research. Very happy to share our experience launching @manifest-cirrp.bsky.social. Thanks for the invitation! 🙏
APPLY NOW for the inaugural TheChristie-PeterMac Senior Clinical Research Fellowship in Experimental Cancer Medicine - this is a unique new partnership where fellows spend 1 year in Manchester 🇬🇧 + 1 year in Melbourne 🇦🇺.
📥 Deadline 15 June
apps.trac.jobs/job-advert/7...
APPLY NOW for the inaugural TheChristie-PeterMac Senior Clinical Research Fellowship in Experimental Cancer Medicine - this is a unique new partnership where fellows spend 1 year in Manchester 🇬🇧 + 1 year in Melbourne 🇦🇺.
📥 Deadline 15 June
apps.trac.jobs/job-advert/7...
🧑⚕️ Delivering clinical trials is a multidisciplinary team effort - our clinical research nurses are dedicated to making sure all our patients receive the best care they can when on clinical trials.
#TeamManchester 🐝
@mcrcnews.bsky.social
🧑⚕️ Delivering clinical trials is a multidisciplinary team effort - our clinical research nurses are dedicated to making sure all our patients receive the best care they can when on clinical trials.
#TeamManchester 🐝
@mcrcnews.bsky.social
You are invited to our inaugural 'Annual Clinical Fellows Showcase'! @christieinstitute.bsky.social
All fellows, supervisors, students & researchers across the Manchester 🐝 ecosystem are welcome to attend.
🗳️ Please sign up:
www.eventbrite.co.uk/e/annual-cli...
You are invited to our inaugural 'Annual Clinical Fellows Showcase'! @christieinstitute.bsky.social
All fellows, supervisors, students & researchers across the Manchester 🐝 ecosystem are welcome to attend.
🗳️ Please sign up:
www.eventbrite.co.uk/e/annual-cli...
DNGR-1, or CLEC9A, most known as a cDC1 receptor for cross-presentation of dead-cell associated antigens - may play a role here.
🔬Great to see labour of love led by Ana finally out now in @jem.org.
Available open access:
hubs.la/Q03mg6Sc0
@reisesousalab.bsky.social
DNGR-1, or CLEC9A, most known as a cDC1 receptor for cross-presentation of dead-cell associated antigens - may play a role here.
🔬Great to see labour of love led by Ana finally out now in @jem.org.
Available open access:
hubs.la/Q03mg6Sc0
@reisesousalab.bsky.social